## Gene Summary
USP5, also known as ubiquitin-specific peptidase 5, is a deubiquitinating enzyme, which plays a critical role in ubiquitin homeostasis by disassembling unanchored polyubiquitin chains. The gene is highly conserved across species and is expressed ubiquitously in human tissues. USP5 targets misfolded or damaged proteins marked by ubiquitin for proteasomal degradation, thus maintaining cellular protein quality. This gene is also involved in the regulation of various cellular processes such as cell cycle progression and signal transduction.

## Gene Drugs, Diseases, Phenotypes, and Pathways
The principal function of USP5 lies in its ability to regulate the ubiquitin-proteasome system, a pathway critical for cellular homeostasis, influencing numerous biological functionalities and disease states. Dysregulation of ubiquitin signaling pathways can contribute to the pathogenesis of several diseases including cancer, neurodegenerative disorders, and immune system diseases. Research indicates a potential link between USP5 and cancer, particularly in its role in tumor growth and survival, through the stabilization of oncogenic proteins. Additionally, USP5 is involved in pathways such as apoptosis and cellular response to stress.

## Pharmacogenetics
While the specific pharmacogenetic profile of USP5 is currently not extensively detailed in relation to particular drugs, its role in the ubiquitin-proteasome pathway makes it a potential target for therapeutic intervention in diseases like cancer. The enzyme's function in the degradation and turnover of proteins implicates it in the mechanism of action of drugs that target protein degradation pathways, such as proteasome inhibitors used in cancer treatment. For instance, bortezomib, a proteasome inhibitor used primarily for treating multiple myeloma, might interact indirectly with USP5 by influencing ubiquitin chain dynamics. Further research into the pharmacogenetics of USP5 could unveil more direct associations with specific drugs and personalized therapy implications.